Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
| Clinical Trial Supplies Market to grow by USD 1.19 billion from 2022 to 2027 | A rise in studies focusing on the pharmaceutical industry is the major market trend - Technavio | ||
| By: PR Newswire Association LLC. - 21 Nov 2023 | Back to overview list |
|
|
NEW YORK, Nov. 21, 2023 /PRNewswire/ -- The clinical trial supplies market size is expected to grow by USD 1.19 billion from 2022 to 2027. In addition, the momentum of the market will progress at a CAGR of over 8.48% during the forecast period, according to Technavio Research. A rise in studies focusing on the pharmaceutical industry is one of the emerging trends in the market. The rising clinical research into different types of cancer has contributed to a greater focus on personalized medicine as pharmaceutical companies seek to invest in the latest market trends. There is an increase in government funding, which is also significantly contributing to the growth of personalized medicine. Precision medicine needs various ways to test interventions. Researchers are required to probe a multitude of factors including genetics and environmental factors that determine a person's response to treatment. Additionally, due to the significant growth of drug-targeted studies, there has been an increase in demand for further clinical trials over the last few years. It is essential for newly approved drugs and applied drugs to be safe, targeted, and have long-term effectiveness, as guaranteed by clinical trial services. Therefore, the increasing number of clinical trial services to ensure the safety of new drugs has fueled the growth and development of clinical trial supplies, which in turn will drive growth. Identify key trends, drivers, and challenges in the market. This report offers an up-to-date analysis of the current market scenario, the latest trends and drivers, and the overall market environment. Read Free PDF Sample Report
Company Profile: Avantor Inc., Bionical Emas Group, Bushu Pharmaceuticals Ltd., Catalent Inc., Clinical Services International Ltd., Clinigen Group Plc, Deutsche Bahn AG, Emsere B.V, GNH India Pharmaceuticals Ltd., International Bonded Couriers Inc., Nuvisan GmbH, Obvio Health USA Inc., Parexel International Corp., PHOENIX Pharmahandel GmbH and Co KG, Piramal Enterprises Ltd.Thermo Fisher Scientific Inc., Vertical Pharma Resources Ltd., Ancillare LP, PCI Pharma Services, Precision Medicine Group LLC Avantor Inc: The company offers clinical trial supplies such as A TKO is a completely managed clinical trial ancillary supply chain.
Clinical Trial Supplies Market: Segmentation Analysis The market has been segmented by end-user (pharmaceutical industry, biologics industry, and medical device industry), type (Phase III, Phase II, Phase IV and BE/BA studies, and Phase I), and geography (North America, Europe, Asia, and Rest of World (ROW)). The market share growth by the pharmaceutical industry segment is significant during the forecast period. Drug discovery and launching a new drug to market are complex processes and need clinical trials to test the safety, effectiveness, and performance of new drugs. Additionally, there is an increase in stringent regulations developed by the FDA to ensure the safety and effectiveness of new and personalized drugs, which is fuelling the need for clinical trials for pharmaceuticals. Hence, such factors are expected to fuel the growth of this segment, which in turn will drive the market growth during the forecast period. North America is estimated to account for 36% of the growth of the global market during the forecast period. There is an increasing prevalence of chronic diseases which is fuelling the number of clinical trials leading to the rising number of life science research activities. One of the main end-users of clinical trial supplies is pharmaceutical companies due to the large number of clinical trials conducted to validate their new drug discoveries and get them out in the market. Hence, such factors are expected to drive the market growth in the region during the forecast period.
"Besides analyzing the current market scenario, our report examines historic data from 2017 to 2021"- Technavio Clinical Trial Supplies Market: Driver & Trend: Driver The growth of the biopharmaceutical industry is one of the key factors driving the growth of the market. There has been a significant change in the dynamics of the biopharmaceutical industry as the pharmaceutical industry looks to the biopharmaceutical industry to discover new drugs and biosimilars launched to the market by new global participants. The emergence of biopharmaceuticals has significantly reduced the number of deaths from cancer and HIV/AIDS in the last few years, which has resulted in an increase in the use of biopharmaceuticals in the global market. Additionally, the rapid expansion of the global biopharmaceutical market has resulted in the development of several other industries, including contract research, contract manufacturing, consumables, and pharmaceuticals. as well as clinical trials. The research and production of drugs and biologics mainly comprises clinical trials to ensure a product's safety, effectiveness, and minimal side effects. Therefore, the growing biopharmaceutical industry leads to the growth of the clinical trials market during the forecast period. Related Reports: The global analytical standards market size is estimated to grow by USD 624.93 million at a CAGR of 6.81% between 2022 and 2027. he report has segmented the market into Type(chromatography, spectroscopy, titrimetry, and physical properties testing), Application(food and beverages, pharmaceuticals and life sciences, environmental, and others), and Geography(North America, Europe, APAC, South America, and Middle East and Africa). The protein expression market size is estimated to grow by USD 2,450.45 million at a CAGR of 13.7% between 2022 and 2027. The report has segmented the market into Solution (products and services), End-user (pharmaceutical and biotechnological companies, academic research, and contract research organizations), and Geography(North America, Europe, Asia, and the Rest of the World (ROW). What are the key data covered in this clinical trial supplies market report?
ToC: Executive Summary Market Landscape Market Sizing Historic Market Sizes Five Forces Analysis Market Segmentation by End-user Market Segmentation by Type Market Segmentation by Geography Customer Landscape Geographic Landscape Drivers, Challenges, & Trends Company Landscape Company Analysis Appendix About Technavio Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios. Contacts
SOURCE Technavio 
|
||
|
|
||
 | Back to overview list | |
View original content to download multimedia: